Updated on 22 September 2026
Innovative therapies for chornic liver diseases (NASH)
CEO at Servatrix Biomed SL
Madrid, Spain
About
We are in the process to optimice the molecule and be ready for preclinical in a few months
Similar opportunities
Partnership
- Research
- Business
- Joint development
Nicola Zanda
Lead Scientist at AItenea Biotech
Madrid, Spain
Expertise
Open to R&D Opportunities | PhD in Molecular Bioscience | Preclinical Development | Bioinformatics
- Healthcare
- Biotech, Pharma and Cosmetics
Ana Mª Fernández Rodríguez, PhD
R&D Scientist at Centro nacional de investigaciones oncológicas (CNIO)
Madrid, Spain
Expertise
Preclinical Drug Testing in Reduced Gravity: Pilot Partners Wanted
- Defence
- Space and Aerospace
- Nano and Microtechnologies
- Biotech, Pharma and Cosmetics
Sebastian Quincha Muñoz
CEO - CeleroSpace at CeleroSpace
Madrid, Spain